Rep. Mike Levin

Driving Veterans Success Act This bill requires that at least 10% of the funds under specified infrastructure programs are expended through veteran-owned small businesses.

Stopping Corrupt Actors from Making Political Action Committees Act or the SCAM PAC Act This bill generally prohibits a political committee from disbursing funds to an entity that is owned or controlled by an individual, or the immediate family member of an individual, who has authority to carry out specified activities for the committee (e.g., soliciting funds) or is employed by the committee to provide it with professional services. This prohibition does not apply to (1) a political committee that certifies that a majority of the funds disbursed by the committee were for expenses other than administrative costs, fundraising costs, and employee salaries; or (2) an authorized committee of a candidate, a committee of a political party, or a separate segregated fund of a corporation or labor organization. Further, the bill prohibits a political committee from employing these individuals or allowing them to volunteer on its behalf if the related entity accepted funds from a political committee.

National Climate Adaptation and Resilience Strategy Act This bill requires the President to identify or appoint a Chief Resilience Officer that must (1) direct a government-wide effort to build resilience to climate change vulnerabilities in the United States in collaboration with existing federal initiatives and interagency adaptation efforts, and (2) create working groups. The officer and the working groups must jointly submit to the President and Congress a strategy for the government to address such vulnerabilities in partnership with nonfederal partners, a plan to implement the strategy, and updates by specified deadlines.

This resolution expresses support for the goals and ideals of PCOS Awareness Month. Polycystic ovary syndrome (PCOS) is caused by a hormone imbalance. Symptoms can include infertility, weight gain, excess hair growth, and acne.

Climate Risk and Emergency Support In Livable Inclusive and Equitable Neighborhoods and Communities Everywhere Act or the Climate RESILIENCE Act This bill makes changes to the Robert T. Stafford Disaster Relief and Emergency Assistance Act to take into account climate change. The bill includes extreme temperature events, such as heat waves or freezes, within the scope of the act and defines resilience for purposes of disaster assistance and mitigation efforts. Federal and state preparedness and mitigation assistance may be used for reducing the impacts of extreme temperatures and improving air quality and mitigating against wildfire smoke.. The bill authorizes implementing predisaster hazard mitigation measures that will be cost-effective and equitable long-term and provide enhanced protection to the community. The Federal Emergency Management Agency (FEMA) must (1) provide technical assistance to underserved and disadvantaged communities for such measures; and (2) provide guidance to implement the latest published editions of relevant consensus-based codes, specifications, and standards that incorporate the latest hazard-resistant designs. The bill includes within the hazard mitigation program requirements the abatement of lead, mold, mildew, radon, asthma, and allergen triggers, or other pollutants and hazardous materials directly caused by a major disaster or emergency. FEMA must report to Congress regarding challenges posed by FEMA requirements for determining the cost-effectiveness of mitigation activities and how such requirements may disproportionately burden underserved or disadvantaged communities.

Guard and Reserve GI Bill Parity Act of 2021 This bill expands eligibility for Post-9/11 GI Bill educational assistance and addresses other Department of Veterans Affairs (VA) programs and benefits. Specifically, the bill expands the type of duty that is eligible for such educational assistance. Beginning on August 1, 2025, types of duty eligible for educational assistance benefits include (1) active duty for training performed by a member of the Armed Forces on or after this date, and (2) active duty for training occurring before this date only if the individual is a member on or after this date. Furthermore, beginning on August 1, 2032, duty eligible for these benefits includes active or inactive duty training performed by a member of the Armed Forces before, on, or after August 1, 2032. Educational assistance eligibility for individuals who performed qualifying types of duty as provided in the bill before August 1, 2025, expires on the latter of (1) August 1, 2040, or (2) the end of the 15-year period after their discharge or release from the Armed Forces. For individuals who performed such duty on or after August 1, 2025, educational assistance eligibility does not expire. Furthermore, the bill provides for the expiration of eligibility applicable to individuals subject to two different periods of eligible duty. The bill also makes adjustments to certain loan fees under the VA home loan program, including the fee for an interest rate reduction refinancing loan. Additionally, the VA must provide information to new veterans that includes a description of the medical care, services, and other benefits they are entitled to through the VA.

Veterans Early Treatment for Chronic Ailment Resurgence through Examinations Act of 2021 or the VET CARE Act of 2021 This bill addresses dental care programs for veterans. Specifically, the bill authorizes the Department of Veterans Affairs (VA) to furnish administrative support to a dental care provider that provides services to a veteran that would not be covered by VA benefits. The bill also requires the VA to implement a pilot program to provide free outpatient dental services and treatment, and related dental appliances, to eligible veterans. Eligible veterans are those who are (1) enrolled in the VA health care system but are not eligible for VA dental care, (2) not receiving regular periodontal care, (3) between 40 and 70 years old, and (4) diagnosed with type 2 diabetes.

PrEP Access and Coverage Act This bill requires private health insurance plans to cover prescription drugs that prevent HIV, including related screenings, diagnostic procedures, administrative fees, and clinical follow-ups, without any cost-sharing obligation for the plan holder. Further, insurance plans must not impose any preauthorization requirement for this coverage. These coverage requirements also apply to public health insurance programs, including Medicare, Medicaid, and the Children's Health Insurance Program. Additionally, the bill prohibits denying, limiting, or qualifying coverage or increasing premiums for disability insurance, long-term care insurance, or life insurance policies based on an individual taking medication for HIV prevention. The bill further requires the Department of Health and Human Services to award grants to states, or directly to eligible local organizations, to provide uninsured individuals and underinsured individuals access to prescription drugs and related services that prevent HIV. The Centers for Disease Control and Prevention also must develop a public awareness campaign that focuses efforts in communities with a high need for HIV prevention treatment.

This bill revises enforcement provisions under the Animal Welfare Act (AWA), including by directing inspectors to confiscate or destroy in a humane manner animals found to be suffering physical or psychological harm as a result of failure to comply with the AWA.

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities for scientific research utilizing data from expanded access to investigational ALS treatments for individuals who are not otherwise eligible for clinical trials.  The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other rare neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases. The Government Accountability Office must report to Congress about the grants provided under this bill, including an analysis of the impact of such grants on research and development of treatments for ALS.